Literature DB >> 32405141

Comment on "Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiotherapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement".

Tejpal Gupta1, Jai Prakash Agarwal1, Søren M Bentzen2.   

Abstract

Year:  2020        PMID： 32405141      PMCID： PMC7218395          DOI： 10.1016/j.ijrobp.2020.04.031

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  6 in total

1.  Hypofractionated accelerated radiotherapy with concurrent carboplatin for locally advanced squamous cell carcinoma of the head and neck.

Authors:  A K Chan; P Sanghera; B A Choo; C McConkey; H Mehanna; S Parmar; P Pracy; J Glaholm; A Hartley
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-09-21       Impact factor: 4.126

2.  Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.

Authors:  Joshua M Bauml; Ravi Vinnakota; Yeun-Hee Anna Park; Susan E Bates; Tito Fojo; Charu Aggarwal; Sewanti Limaye; Nevena Damjanov; Jessica Di Stefano; Christine Ciunci; Eric M Genden; Juan P Wisnivesky; Rocco Ferrandino; Ronac Mamtani; Corey J Langer; Roger B Cohen; Keith Sigel
Journal:  J Natl Cancer Inst       Date:  2019-05-01       Impact factor: 13.506

3.  Global Epidemiology of Head and Neck Cancers: A Continuing Challenge.

Authors:  Bhawna Gupta; Newell W Johnson; Narinder Kumar
Journal:  Oncology       Date:  2016-06-01       Impact factor: 2.935

4.  Hypofractionated accelerated radiotherapy with concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck.

Authors:  Paul Sanghera; Chris McConkey; Kean-Fatt Ho; John Glaholm; Andrew Hartley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-01-22       Impact factor: 7.038

5.  NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.

Authors:  A Dimitrios Colevas; Sue S Yom; David G Pfister; Sharon Spencer; David Adelstein; Douglas Adkins; David M Brizel; Barbara Burtness; Paul M Busse; Jimmy J Caudell; Anthony J Cmelak; David W Eisele; Moon Fenton; Robert L Foote; Jill Gilbert; Maura L Gillison; Robert I Haddad; Wesley L Hicks; Ying J Hitchcock; Antonio Jimeno; Debra Leizman; Ellie Maghami; Loren K Mell; Bharat B Mittal; Harlan A Pinto; John A Ridge; James Rocco; Cristina P Rodriguez; Jatin P Shah; Randal S Weber; Matthew Witek; Frank Worden; Weining Zhen; Jennifer L Burns; Susan D Darlow
Journal:  J Natl Compr Canc Netw       Date:  2018-05       Impact factor: 11.908

6.  Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement.

Authors:  David J Thomson; David Palma; Matthias Guckenberger; Panagiotis Balermpas; Jonathan J Beitler; Pierre Blanchard; David Brizel; Wilfred Budach; Jimmy Caudell; June Corry; Renzo Corvo; Mererid Evans; Adam S Garden; Jordi Giralt; Vincent Gregoire; Paul M Harari; Kevin Harrington; Ying J Hitchcock; Jorgen Johansen; Johannes Kaanders; Shlomo Koyfman; J A Langendijk; Quynh-Thu Le; Nancy Lee; Danielle Margalit; Michelle Mierzwa; Sandro Porceddu; Yoke Lim Soong; Ying Sun; Juliette Thariat; John Waldron; Sue S Yom
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-04-14       Impact factor: 7.038
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.